Back to search
Post Stroke Spastic Hemiplegia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post Stroke Spastic Hemiplegia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post Stroke Spastic Hemiplegia trials you may qualify forThis research evaluate the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) for treating spasticity in the wrist flexor muscles (flexor carpi ulnaris -…
Sensory and motor impairments following stroke can lead to substantial disability involving the arm and hand. The investigator hypothesized that excessive local…
There is debate regarding the efficiency of different dilutions of Botulin toxin type A (BTX-A) injections. Some authors believe that highly diluted BTX-A injec…
Stroke is a leading cause of long-term disability, frequently resulting in impaired upper limb motor function and spasticity. Although Botulinum Toxin Type A (B…
Tolperison is an antispastic agent used in the treatment of spasticity. Studies on tolperison are limited, and the literature on its effectiveness against spast…
This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation. This retrospe…